Compile Data Set for Download or QSAR
Found 36 Enz. Inhib. hit(s) with all data for entry = 50011135
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50235980(2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...)
Show SMILES CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1
Affinity DataIC50: 0.540nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50004058((2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-yl...)
Show SMILES CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(O)=O
Show InChI InChI=1S/C22H36N2O5S/c1-2-3-16-30(27,28)24-21(22(25)26)17-19-7-9-20(10-8-19)29-15-5-4-6-18-11-13-23-14-12-18/h7-10,18,21,23-24H,2-6,11-17H2,1H3,(H,25,26)/t21-/m0/s1
Affinity DataIC50: 1.20nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 3.30nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 5.5nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50235980(2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...)
Show SMILES CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1
Affinity DataIC50: 8nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 9.90nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 11nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50235980(2-((2S,5R,8S,11S)-5-benzyl-11-(3-guanidinopropyl)-...)
Show SMILES CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
Show InChI InChI=1S/C27H40N8O7/c1-15(2)22-25(41)33-17(10-7-11-30-27(28)29)23(39)31-14-20(36)32-18(13-21(37)38)24(40)34-19(26(42)35(22)3)12-16-8-5-4-6-9-16/h4-6,8-9,15,17-19,22H,7,10-14H2,1-3H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30)/t17-,18-,19+,22-/m0/s1
Affinity DataIC50: 15nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50429461(CHEMBL2332369)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
Show InChI InChI=1S/C43H77N15O17/c1-18(2)13-24(35(68)51-23(10-8-12-50-43(47)48)34(67)58-32(21(6)61)41(74)75)53-39(72)28(17-59)56-38(71)26(15-29(62)63)54-36(69)25(14-19(3)4)52-37(70)27(16-30(64)65)55-40(73)31(20(5)60)57-33(66)22(44)9-7-11-49-42(45)46/h18-28,31-32,59-61H,7-17,44H2,1-6H3,(H,51,68)(H,52,70)(H,53,72)(H,54,69)(H,55,73)(H,56,71)(H,57,66)(H,58,67)(H,62,63)(H,64,65)(H,74,75)(H4,45,46,49)(H4,47,48,50)/t20-,21-,22+,23+,24+,25+,26+,27+,28+,31+,32+/m1/s1
Affinity DataIC50: 33nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 50nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 63nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 66nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 72nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta3 (Gly27 to Asp718 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 88nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50429461(CHEMBL2332369)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)[C@@H](C)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
Show InChI InChI=1S/C43H77N15O17/c1-18(2)13-24(35(68)51-23(10-8-12-50-43(47)48)34(67)58-32(21(6)61)41(74)75)53-39(72)28(17-59)56-38(71)26(15-29(62)63)54-36(69)25(14-19(3)4)52-37(70)27(16-30(64)65)55-40(73)31(20(5)60)57-33(66)22(44)9-7-11-49-42(45)46/h18-28,31-32,59-61H,7-17,44H2,1-6H3,(H,51,68)(H,52,70)(H,53,72)(H,54,69)(H,55,73)(H,56,71)(H,57,66)(H,58,67)(H,62,63)(H,64,65)(H,74,75)(H4,45,46,49)(H4,47,48,50)/t20-,21-,22+,23+,24+,25+,26+,27+,28+,31+,32+/m1/s1
Affinity DataIC50: 100nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 141nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 178nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 303nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 319nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 378nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 608nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 623nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 657nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 709nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 806nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 921nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-5/beta-1(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 1.08E+3nMAssay Description:Inhibition of fibronectin binding to recombinant human integrin alpha5 (Phe42 to Tyr995 residues) beta1 (Gln21 to Asp728 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-6(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 1.97E+3nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta6 (Gly22 to Asn707 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545180(CHEMBL4643939)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)CC2(CCCCC2)CNC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C30H44N8O7.C2HF3O2/c31-29(32)33-13-7-10-20-26(43)34-17-24(40)37-22(15-25(41)42)28(45)38-21(14-19-8-3-1-4-9-19)27(44)35-18-30(16-23(39)36-20)11-5-2-6-12-30;3-2(4,5)1(6)7/h1,3-4,8-9,20-22H,2,5-7,10-18H2,(H,34,43)(H,35,44)(H,36,39)(H,37,40)(H,38,45)(H,41,42)(H4,31,32,33);(H,6,7)/t20-,21+,22-;/m0./s1
Affinity DataIC50: 3.95E+3nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 4.86E+3nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 4.93E+3nMAssay Description:Inhibition of vitronectin binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta5 (Gly24 to Asn719 residues) expressed in CHO c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-V/beta-8(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545182(CHEMBL4636873)
Show SMILES OC(=O)C(F)(F)F.COc1c2NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)c1ccc2
Show InChI InChI=1S/C29H36N8O8.C2HF3O2/c1-45-24-17-9-5-10-18(24)35-27(43)20(13-16-7-3-2-4-8-16)37-28(44)21(14-23(39)40)34-22(38)15-33-26(42)19(36-25(17)41)11-6-12-32-29(30)31;3-2(4,5)1(6)7/h2-5,7-10,19-21H,6,11-15H2,1H3,(H,33,42)(H,34,38)(H,35,43)(H,36,41)(H,37,44)(H,39,40)(H4,30,31,32);(H,6,7)/t19-,20+,21-;/m0./s1
Affinity DataIC50: 6.88E+3nMAssay Description:Inhibition of latency-associated peptide/TGF-beta binding to recombinant human integrin alphaV (Phe31 to Val992 residues) beta8 (Glu43 to Arg684 resi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545183(CHEMBL4648191)
Show SMILES OC(=O)C(F)(F)F.C[Si]1(C)C[C@H]2N(C1)C(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC2=O
Show InChI InChI=1S/C27H40N8O7Si.C2HF3O2/c1-43(2)14-20-25(41)33-17(9-6-10-30-27(28)29)23(39)31-13-21(36)32-18(12-22(37)38)24(40)34-19(26(42)35(20)15-43)11-16-7-4-3-5-8-16;3-2(4,5)1(6)7/h3-5,7-8,17-20H,6,9-15H2,1-2H3,(H,31,39)(H,32,36)(H,33,41)(H,34,40)(H,37,38)(H4,28,29,30);(H,6,7)/t17-,18-,19+,20+;/m0./s1
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545184(CHEMBL4642869)
Show SMILES OC(=O)C(F)(F)F.NC(=N)NCCC[C@@H]1NC(=O)C2(CCCCC2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O
Show InChI InChI=1S/C28H40N8O7.C2HF3O2/c29-27(30)31-13-7-10-18-23(40)32-16-21(37)33-20(15-22(38)39)24(41)34-19(14-17-8-3-1-4-9-17)25(42)36-28(26(43)35-18)11-5-2-6-12-28;3-2(4,5)1(6)7/h1,3-4,8-9,18-20H,2,5-7,10-16H2,(H,32,40)(H,33,37)(H,34,41)(H,35,43)(H,36,42)(H,38,39)(H4,29,30,31);(H,6,7)/t18-,19+,20-;/m0./s1
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Division of Organic Chemistry CSIR-National Chemical Laboratory (NCL)

Curated by ChEMBL
LigandPNGBDBM50545181(CHEMBL4633117)
Show SMILES OC(=O)C(F)(F)F.CC1(C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC1=O
Show InChI InChI=1S/C25H36N8O7.C2HF3O2/c1-25(2)23(40)32-15(9-6-10-28-24(26)27)20(37)29-13-18(34)30-17(12-19(35)36)21(38)31-16(22(39)33-25)11-14-7-4-3-5-8-14;3-2(4,5)1(6)7/h3-5,7-8,15-17H,6,9-13H2,1-2H3,(H,29,37)(H,30,34)(H,31,38)(H,32,40)(H,33,39)(H,35,36)(H4,26,27,28);(H,6,7)/t15-,16+,17-;/m0./s1
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of fibrinogen binding to human platelet integrin alpha2b beta3 by ELISA based solid phase binding assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid